Prasugrel versus clopidogrel in patients with acute coronary syndromes.: Results of the TRITON-TIMI 38 trial

被引：0
|
作者：
Preohrazhensky, D. V.
机构：
来源：
KARDIOLOGIYA | 2008年 / 48卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：72 / 73
页数：2
相关论文
共 50 条
  • [31] Balancing efficacy and safety in the TRITON-TIMI 38 trial
    Neumann, Franz-Josef
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2009, 11 (0G) : G14 - G17
  • [32] Ticagrelor versus Clopidogrel in Acute Coronary Syndromes.
    Tomoda, Haruo
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (24): : 2385 - 2385
  • [33] Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial
    Montalescot, Gilles
    Wiviott, Stephen D.
    Brounwald, Eugene
    Murphy, Sabina A.
    Gibson, C. Michael
    McCabe, Carolyn H.
    Antman, Elliott M.
    LANCET, 2009, 373 (9665): : 723 - 731
  • [34] Prasugrel versus Clopidogrel for Acute Coronary Syndromes Reply
    Roe, Matthew T.
    Ohman, E. Magnus
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (02): : 188 - 189
  • [35] Prasugrel (Efient((R))) - Clinical Place Value according to TRITON-TIMI 38
    Christ, G.
    JOURNAL FUR KARDIOLOGIE, 2009, 16 (11-12): : 453 - 455
  • [36] Transfusion Requirements and Outcomes In the Cohort of Patients Undergoing-Isolated CABG Treated with Prasugrel or Clopidogrel: TRITON-TIMI 38 Data Analysis
    Goodnough, Lawrence T.
    Despotis, George
    Smith, Peter K.
    Levy, Jerrold
    Poston, Robert
    Short, Mary
    Weerakkody, Govinda
    Lenarz, LeRoy
    BLOOD, 2010, 116 (21) : 482 - 483
  • [37] Clinical outcomes for prasugrel versus clopidogrel are consistent among patients from TRITON-TIMI 38 with unstable angina or non-ST-elevation myocardial infarction
    De Servi, S.
    Goedicke, J.
    Schirmer, A.
    Widimsky, P.
    EUROPEAN HEART JOURNAL, 2013, 34 : 882 - 882
  • [38] Cardiovascular Outcomes of Women and Men with Acute Coronary Syndromes and Angiographically Confirmed Epicardial Coronary Artery Disease In TRITON-TIMI 38
    Mega, Jessica L.
    Wiviott, Stephen D.
    Mohanavolu, Satishkumar
    Nicolau, Jose C.
    McCabe, Carolyn H.
    Antman, Elliott M.
    Braunwald, Eugene
    CIRCULATION, 2008, 118 (18) : S967 - S967
  • [39] Relationship between Exposure to the Prasugrel Active Metabolite with TIMI Major/Minor Bleeding in TRITON-TIMI 38
    Salazar, Daniel E.
    Ernest, C. Steven, II
    Wrishko, Rebecca E.
    Weerakkody, Govinda J.
    Small, David S.
    Li, Ying G.
    Rhohatagi, Shashank
    Domseif, Bruce E.
    Sankyo, Daiichi
    Ni, Lan
    Antman, Elliot M.
    Wiviott, Stephen D.
    Macias, William L.
    Riesmeyer, Jeffrey S.
    CIRCULATION, 2008, 118 (18) : S815 - S815
  • [40] Lack of Benefit and Evidence for Harm with Prasugrel as Compared to Clopidogrel in Patients with a History of TIA/CVA Undergoing PCI: Insights from TRITON-TIMI 38
    Desai, Nihar R.
    Antman, Elliott M.
    Murphy, Sabina A.
    Wiviott, Stephen D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A63 - A63
12345